Equities

Codelab Capital AS

Codelab Capital AS

Actions
  • Price (EUR)0.031
  • Today's Change-0.001 / -3.13%
  • Shares traded0.00
  • 1 Year change0.00%
  • Beta--
Data delayed at least 15 minutes, as of Jun 07 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Codelab Capital AS, formerly Patientsky Group AS, is a Norway-based Information Technology (IT) solutions provider. The Company is developing eHealth solutions for global healthcare and offers both Software-as-aService (SaaS), Platform-as-a-Service (PaaS) and Value-Added Services (VAS) solutions to healthcare providers and their patients. The Company's main products are the PatientSky 360 Platform, electronic health record systems and medication modules. The PatientSky 360 Platform is the core of the group's business, and is a platform that provides all the necessary building blocks for internally and partner developed modules of scalable healthcare software.

  • Revenue in NOK (TTM)--
  • Net income in NOK--
  • Incorporated2017
  • Employees200.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.